The updated document, developed by the American Heart Association and American Stroke Association, also emphasizes the potential benefits of caregiver training and MR imaging. 

“Improving ancillary shielding barriers is paramount,” according to the authors of a brand new analysis. 

The new Shockwave Medical M5+ peripheral intravascular lithotripsy (IVL) catheter made its debut at ACC.22. 

However, researchers noted, there was still a clear improvement in stroke risk.

Given high mortality and a high threat of limb loss for CLTI patients, the statement aims to standardize core competencies and improve patient outcomes. 

Researchers introduced decision support tools to 13 different hospitals, tracking the overall impact on shared-decision making and patient knowledge. 

Vivasure Medical will use the funds to advance clinical development and attempt to secure regulatory approval of its vessel closure devices.

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance.